Biotech / Pharma
Vigil Neuroscience
Biotech / Pharma
Clinical-stage biotech developing microglia-targeted antibody and small-molecule therapies for neurodegenerative disease; IPO'd in 2022, acquired by Sanofi in 2025.
Founded
Region
Investors
People